Filing Details

Accession Number:
0001140361-18-030426
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-06-28 16:21:21
Reporting Period:
2018-06-26
Accepted Time:
2018-06-28 16:21:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1301501 Achaogen Inc AKAO Pharmaceutical Preparations (2834) 680533693
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1654446 Blake Wise C/O Achaogen, Inc.
1 Tower Place #300
South San Francisco CA 94080
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-06-26 3,450 $0.00 97,157 No 4 A Direct
Common Stock Disposition 2018-06-26 1,194 $9.59 95,963 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2018-06-26 16,100 $0.00 16,100 $10.64
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
16,100 2028-02-08 No 4 A Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 178,416 Indirect See Footnote
Footnotes
  1. On February 8, 2018, the issuer granted the reporting person Restricted Stock Units ("RSUs") and a stock option that each vest upon the achievement of certain milestones. On June 26, 2018, one of the milestones was achieved, resulting in vesting of a portion of the RSUs and shares subject to the option.
  2. Includes (i) 2,208 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2018 and (ii) 67,300 RSUs.
  3. The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of RSUs of the Issuer.
  4. The shares are held directly by the Blake A. Wise Living Trust.
  5. The option is fully vested and exercisable.